| Electromagnetic waves and human health F Ozdemir, A Kargi Electromagnetic Waves 22, 475-491, 2011 | 67 | 2011 |
| Use of cryoablation beyond the prostate S Yılmaz, M Özdoğan, M Cevener, A Ozluk, A Kargi, F Kendiroglu, ... Insights into imaging 7, 223-232, 2016 | 45 | 2016 |
| Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer A Bisgin, A Kargi, AD Yalcin, C Aydin, D Ekinci, B Savas, S Sanlioglu BMC cancer 12, 1-5, 2012 | 36 | 2012 |
| Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis AD Yalcin, S Gumuslu, GE Parlak, A Bisgin, M Yildiz, A Kargi, ... Immunopharmacology and immunotoxicology 34 (6), 1047-1053, 2012 | 27 | 2012 |
| Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatment AD Yalcin, A Bisgin, A Kargi, RM Gorczynski Medical Science Monitor: International Medical Journal of Experimental and …, 2012 | 26 | 2012 |
| IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer. A Kargi, AD Yalcin, N Erin, B Savas, HH Polat, RM Gorczynski Clinical laboratory 58 (5-6), 501-505, 2012 | 24* | 2012 |
| Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to … AD Yalcin, RM Gorczynski, GE Parlak, A Kargi, A Bisgin, E Sahin, S Kose, ... Clin Lab 58 (1-2), 89-96, 2012 | 24 | 2012 |
| Complementary/alternative medicine experience in cancer patients: a questionnaire-based survey G Gököz Doğu, A Kargı, Ö Tanrıverdi, A Yaren, G Demiray, ... UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi, 2014 | 22 | 2014 |
| MDR1 single nucleotide polymorphism C3435T in Turkish patients with non-small-cell lung cancer GG Dogu, A Kargi, S Turgut, C Ayada, BY Taskoylu, G Demiray, A Yaren, ... Gene 506 (2), 404-407, 2012 | 20 | 2012 |
| The importance of COX-2 expression as prognostic factor in early breast cancer A Kargi, M Uysal, H Bozcuk, HS Coskun, B Savas, M Ozdogan J buon 18 (3), 579-84, 2013 | 19 | 2013 |
| Blood eosinophil and platelet levels, proteomics patterns of trail and CXCL8 correlated with survival in bevacizumab treated metastatic colon cancers AD Yalcin, A Kargi, S Gumuslu, LG Strauss Clin Lab 60 (2), 339-40, 2014 | 15 | 2014 |
| Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F] Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers B Celik, AD Yalcin, A Bisgin, A Dimitrakopoulou-Strauss, A Kargi, ... Medical Science Monitor: International Medical Journal of Experimental and …, 2013 | 15 | 2013 |
| Isolated and solitary splenic metastasis detected by positron emission tomography in a patient with malignant melanoma: case report and review of the literature CA Sen, A Kargi, V Kaya, O Tanriverdi Contemporary Oncology/Współczesna Onkologia 17 (2), 214-217, 2013 | 13 | 2013 |
| Primary splenic angiosarcoma diagnosed after splenectomy for spontaneous rupture B Özcan, M Çevener, AO Kargı, H Dikici, A Yıldız, M Özdoğan, A Gürkan Turkish journal of surgery 34 (1), 68, 2018 | 12 | 2018 |
| Serum levels of HMGB1 have a diagnostic role in metastatic renal cell cancer A Kargı, Ö Demirpençe, Ş Gündüz, S Göktaş, AS Alikanoǧlu, M Yıldırım Cancer Biomarkers 17 (1), 17-20, 2016 | 11 | 2016 |
| Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage … M Uysal, M Ozdogan, A Kargi, S Gunduz, S Sezgin Goksu, A Murat Tatli, ... J BUON 19 (4), 980-984, 2014 | 11 | 2014 |
| Increased serum S-TRAIL level in newly diagnosed stage-IV lung adenocarcinoma but not squamous cell carcinoma is correlated with age and smoking A Kargi, A Bisgin, AD Yalcin, AB Kargi, E Sahin, S Gumuslu Asian Pacific Journal of Cancer Prevention 14 (8), 4819-4822, 2013 | 9 | 2013 |
| Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer Y Ilhan, AM Tatli, F Teker, AH Onder, F Kose, C Geredeli, M Karaagac, ... International Journal of Gynecologic Cancer 32 (4), 2022 | 6 | 2022 |
| Metronomic oral chemotherapy with old agents in patients with heavily treated metastatic breast cancer H Mutlu, FY Musri, M Artaç, A Kargi, M Özdogan, H Bozcuk Journal of Cancer Research and Therapeutics 11 (2), 287-290, 2015 | 6 | 2015 |
| Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer D Arslan, D Tural, T Koca, D Tastekin, A Kaymak Cerkesli, H Basaran J BUON 20 (2), 573-579, 2015 | 6 | 2015 |
Mustafa Özdoğan, MDTıbbi Onkoloji, Memorial Sağlık Grubu在 memorial.com.tr 的电子邮件经过验证
